Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BIO-TECHNE Corp TECH

Bio-Techne Corporation is a global life sciences company providing tools and bioactive reagents for the research and clinical diagnostic communities. The Company's products assist scientific investigations into biological processes and the nature and progress of specific diseases. The Company, in partnership with Wilson Wolf, is creating products such as media and cytokines that are... see more

Recent & Breaking News (NDAQ:TECH)

Bio-Techne To Present At The 2020 Wells Fargo Virtual Healthcare Conference

PR Newswire September 3, 2020

Bio-Techne Corporation and Leica Biosystems are Accelerating Disease Research with RNAscope(TM) COVID-19 Probes and the BOND RX*

PR Newswire August 19, 2020

Bio-Techne Announces Release of a New SARS-CoV-1/2 Spike RBD LlaMABody(TM) Recombinant Antibody that Blocks Viral Entry

PR Newswire August 11, 2020

NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler

Business Wire August 6, 2020

Bio-Techne And NanoString Announce Offering Of RNAscope Reagents Validated For Use With The GeoMx Digital Spatial Profiler

PR Newswire August 6, 2020

Bio-Techne Releases Fourth Quarter Fiscal 2020 Results

PR Newswire August 4, 2020

Bio-Techne Declares Dividend

PR Newswire August 4, 2020

Bio-Techne Announces Appointment Of Julie L. Bushman To Its Board Of Directors

PR Newswire August 3, 2020

Bio-Techne And Kantaro Biosciences To Launch A Quantitative Research Use Only COVID-19 Serology Test

PR Newswire August 3, 2020

Bio-Techne Announces Launch Of ExoCovid-19 Test For Detection Of SARS-CoV-2 In Patient Samples

PR Newswire July 21, 2020

Bio-Techne Announces Commercial Release Of New Assay For Detecting ASOs, miRNAs, And siRNAs In Tissue

PR Newswire July 20, 2020

Bio-Techne To Host Conference Call On August 4, 2020 To Announce Fourth Quarter 2020 Financial Results

PR Newswire July 13, 2020

Bio-Techne And ZERO - The End Of Prostate Cancer Announce Partnership To Fund Education And Awareness Campaigns To Empower Men With Prostate Cancer

PR Newswire June 11, 2020

Bio-Techne Continues to Expand Its Portfolio to Support SARS-CoV-2 and COVID-19 Research and Therapeutic Development

PR Newswire June 9, 2020

Bio-Techne Announces Release of GMP ProDots Proteins to Support Cell and Gene Therapy Manufacturing Workflows

PR Newswire June 8, 2020

Bio-Techne To Present At The Jefferies Virtual Healthcare Conference

PR Newswire May 27, 2020

Leica Biosystems and Bio-Techne Announce European Launch of the CE-IVD RNAscope In Situ Hybridization Detection Kit

PR Newswire May 26, 2020

Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test

PR Newswire May 19, 2020

Bio-Techne Announces Release of GMP Cloudz(TM) Human T Cell Activation Kit

PR Newswire May 11, 2020

Bio-Techne Announces Publication of ExoDx(TM) Prostate (IntelliScore) EPI Test Clinical Utility Study

PR Newswire May 7, 2020